Abstract:Appendiceal mucinous neoplasms have been the focus of considerable debate in recent years. We histologically classified 70 appendiceal mucinous neoplasms into three categories: 32 mucinous adenoma, 23 mucinous neoplasm of uncertain malignant potential, and 15 mucinous adenocarcinomas. Immunohistochemistry was performed for 24 proteins in different functional categories, specifically, oncogenic proteins (bcl-2, beta-catenin, CEA, C-erbB2, c-kit, Cox-2, Cyclin D1, EGFR, Ki-67, NF-kappaB, VEGF), tumor suppressors (E-cadherin, FHIT, hMLH1, p53, p63, smad4), cell-cycle regulators (p21, p27, p16), and mucin proteins (MUC1, MUC2, MUC5AC, MUC6). Our data showed that 9 out of the 24 proteins were more frequently altered in the mucinous adenocarcinoma group than in the mucinous adenoma group (P<0.05), including beta-catenin (13% in mucinous adenoma vs 60% in mucinous adenocarcinoma), CyclinD1 (44 vs 87%), Ki-67 (high labeling index: 31 vs 67%), NF-kappaB (19 vs 60%), VEGF (16 vs 87%), E-cadherin (0 vs 47%), p53 (6 vs 40%), MUC2 (9 vs 67%), and MUC5AC (3 vs 40%). The distinct immunoexpression profile of mucinous neoplasm of uncertain malignant potential was placed between those of mucinous adenoma and mucinous adenocarcinoma (P<0.05). Moreover, the mucinous adenoma, mucinous neoplasm of uncertain malignant potential, and mucinous adenocarcinoma categories displayed differences in terms of the number of altered markers among the nine proteins (P<0.05; mean 1.4 vs 2.6 vs 5.5, respectively). In mucinous adenocarcinoma, the p53 status was related to disease-free survival and overall survival of patients (P<0.05, both). NF-kappaB status and the number of altered protein markers made statistically marginal impacts on disease-free survival; also beta-catenin loss, on overall survival of patients. In conclusion, protein immunoexpression profiles may facilitate the classification of appendiceal mucinous neoplasms. In our study, the three tumor categories of mucinous adenoma, mucinous neoplasm of uncertain malignant potential, and mucinous adenocarcinoma exhibited distinct immunoexpression profiles. Five and more altered protein markers, p53 overexpression, NF-kappaB positivity, and beta-catenin loss were predictive factors of adverse clinical outcomes in appendiceal mucinous adenocarcinomas.

Incidence and survival trends for appendiceal mucinous adenocarcinoma: an analysis of 3237 patients in the Surveillance, Epidemiology, and End Results database.

A Population-Based and Propensity Score-Matched Investigation of the Occurrence, Management, and Prognosis of Anal Mucinous Adenocarcinoma Patients

Epidemiology of and Prognostic Factors for Appendiceal Carcinomas: a Retrospective, Population-Based Study

The Management and Prognostic Prediction of Adenocarcinoma of Appendix

Predicting Survival in Mucinous Adenocarcinoma of the Appendix: Demographics, Disease Presentation, and Treatment Methodology

Nomogram To Predict Overall Survival And Disease-Specific Survival With Appendiceal Mucinous Adenocarcinoma

Epidemiology and Survival Outcomes of Mucinous Adenocarcinomas: A SEER Population-Based Study.

Risk Factors of Peritoneal Metastasis in Primary Appendiceal Tumor

The Analysis of Management of 12 Cases of Primary Adenocarcinoma of Appendix

Risk and Prognostic Factors for Small Bowel Adenocarcinoma: A Multicenter Retrospective Observational Study in China

Differential protein immunoexpression profiles in appendiceal mucinous neoplasms: a special reference to classification and predictive factors

Clinical Features and Survival Analysis of Primary Appendiceal Mucinous Neoplasm

Survival Profile and Prognostic Factors for Appendiceal Mixed Neuroendocrine Non-neuroendocrine Neoplasms: A SEER Population-Based Study

Increased risk of malignancy for patients older than 40 years with appendicitis and an appendix wider than 10 mm on computed tomography scan: A post hoc analysis of an EAST multicenter study

Prognosis and Nomogram for Predicting Postoperative Survival of Duodenal Adenocarcinoma: A Retrospective Study in China and the SEER Database

A retrospective clinicopathological analysis of appendiceal tumors from 3,744 appendectomies: a single-institution study

Appendiceal adenocarcinoma-patterns of tumor spread and prognosis

Impact of Nonappendiceal Cancer-Specific Death on Overall Survival: a Competing Risk Analysis

Prognostic Significance of CEA, Ki67 and P53 in Pseudomyxoma Peritonei of Appendiceal Origin

Analysis on Pathology Features and Prognosis of Appendiceal Mucinous Neoplasm

Clinicopathological Characteristics and Prognosis of Colorectal Mucinous Adenocarcinoma and Nonmucinous Adenocarcinoma: a Surveillance, Epidemiology, and End Results (SEER) Population-Based Study